Vacino Biotech Co., Ltd.
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
Vacino Biotech focuses on innovations for HLA-peptide based vaccine (9-mer peptide), nucleic acid medicine (microRNA) and brain delivery technology (targeting peptide) for the indication of infectious disease, neurodegenerative disease and oncology.
Core products:
- Oral universal COVID vaccine against SARS-CoV-2 variants
- A microRNA-based anti-neuroinflammation therapeutics
- A brain shuttled anti-Her2 antibody for treating the peripheral and intracranial tumors.
- An oral bioavailable brain-targeting LNP for delivering the oligonucleotide and large molecule therapeutics
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}